Lobbying disclosures · Lobbying report
TFX: third_quarter 2026 lobbying report
Educated key government stakeholders on Teleflexs research and development capabilities in support of US Service members. Educated key government stakeholders on Teleflexs research and development capabilities in support of US Service members.
Follow TFX- Became public
- Oct 8, 2026, 3:05 PM EDT
- Event / period date
- Not stated
- Collected
- Nov 10, 2026, 11:11 PM EST
Why this is connected
Legal-name match: TELEFLEX INCORPORATED is TELEFLEX INC (https://www.sec.gov/Archives/edgar/data/96943/), differing only in punctuation, "the" or suffix spelling (Corp/Corporation).
Reported lobbying amounts
Income: $20,000.00
These are different reporting measures. They are not added together or treated as spending on one particular bill.
Source evidence
Read the source excerpt or record
{"url":"https://lda.gov/api/v1/filings/0e7725ce-27c2-4b78-a40f-5dd20040b557/","filing_uuid":"0e7725ce-27c2-4b78-a40f-5dd20040b557","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/0e7725ce-27c2-4b78-a40f-5dd20040b557/print/","filing_document_content_type":"text/html","income":"20000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Stacey Scholl","dt_posted":"2026-10-08T15:05:27-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"800 Maine Ave. SW Floor 7","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20024","registrant":{"id":75557,"url":"https://lda.gov/api/v1/registrants/75557/","house_registrant_id":36051,"name":"CORNERSTONE GOVERNMENT AFFAIRS, INC.","description":"Government relations and consulting.","address_1":"800 Maine Ave. SW Floor 7","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20024","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"STACEY SCHOLL","contact_telephone":"+1 202-370-1015","dt_updated":"2026-07-15T15:23:57.752080-04:00"},"client":{"id":66262,"url":"https://lda.gov/api/v1/clients/66262/","client_id":66262,"name":"TELEFLEX INCORPORATED","general_description":"Medical technologies","client_government_entity":null,"client_self_select":false,"state":"PA","state_display":"Pennsylvania","country":"US","country_display":"United States of America","ppb_state":"PA","ppb_state_display":"Pennsylvania","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2025-04-01"},"lobbying_activities":[{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"Educated key government stakeholders on Teleflexs research and development capabilities in support of US Service members.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":139293,"prefix":"mr","prefix_display":"MR.","first_name":"JONATHAN","nickname":null,"middle_name":null,"last_name":"MILLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":25,"name":"Defense, Dept of (DOD)"}]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Educated key government stakeholders on Teleflexs research and development capabilities in support of US Service members.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":139293,"prefix":"mr","prefix_display":"MR.","first_name":"JONATHAN","nickname":null,"middle_name":null,"last_name":"MILLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":25,"name":"Defense, Dept of (DOD)"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}Congressional trading in TFX
These disclosures provide context. Their presence does not establish a link between a trader and the event.
- Aug 13, 2025$1K–$15K
Rep. Lisa C. McClain (R-MI-9)
$1K–$15K · Traded Jul 22, 2025 · disclosed Aug 13, 2025 · Spouse
- Aug 13, 2025$1K–$15K
Rep. Lisa C. McClain (R-MI-9)
$1K–$15K · Traded Jul 16, 2025 · disclosed Aug 13, 2025 · Spouse
- Mar 27, 2025$1K–$15K
Rep. Robert P. Bresnahan, Jr. (R-PA-8)
$1K–$15K · Traded Feb 25, 2025 · disclosed Mar 27, 2025
- Nov 8, 2023$1K–$15K
- Aug 13, 2023$15K–$50K
Rep. Daniel S. Goldman (D-NY-10)
$15K–$50K · Traded Jul 12, 2023 · disclosed Aug 13, 2023
- May 19, 2023$15K–$50K
Rep. Daniel S. Goldman (D-NY-10)
$15K–$50K · Traded Apr 10, 2023 · disclosed May 19, 2023
- Dec 1, 2014$15K–$50K
Sen. Susan M. Collins (R-ME)
$15K–$50K · Traded Nov 10, 2014 · disclosed Dec 1, 2014 · Spouse
Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.